Skip to main content
. 2021 Sep 21;18(18):9928. doi: 10.3390/ijerph18189928

Table 2.

The burden of comorbidities in the study group in the entire study group and depending on the recruitment mode (percentages).

Comorbidity All Subjects
n = 5479
Randomized
n = 1164
Self-Selected
n = 4315
p
Any comorbidities 14.0 18.0 12.9 <0.001
Coronary artery disease 0.6 1.1 0.4 0.01
Myocardial infarction 0.5 0.9 0.3 0.05
Heart failure 0.3 0.5 0.3 0.2
Valvular heart disease 0.4 0.8 0.3 0.07
Stroke 0.3 0.6 0.2 0.07
Chronic obstructive pulmonary disease 2.0 3.2 1.7 0.003
Asthma 6.7 7.1 6.6 0.6
Chronic Allergic Disease 11.5 9.9 11.9 0.06
Diabetes 6.5 9.7 5.6 <0.001
Cancer 4.2 6.4 3.6 <0.001
Chronic Rheumatological Disease 3.5 5.3 3.0 <0.001
Autoimmune disease 6.7 6.2 6.9 0.4

Legend: n—number of participants; pp-value.